tiprankstipranks
Trending News
More News >
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
US Market

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Financial Statements

Compare
3 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Financial Overview

Guangzhou Baiyunshan Pharmaceutical Holdings Company's market cap is currently $5.77B. The company's EPS TTM is $0.15546272000000003; its P/E ratio is 9.62; and it has a dividend yield of 7.36%. Guangzhou Baiyunshan Pharmaceutical Holdings Company is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 74.99B¥ 75.52B¥ 70.79B¥ 69.01B¥ 61.67B
Gross Profit¥ 12.52B¥ 14.19B¥ 13.28B¥ 13.23B¥ 10.44B
Operating Income¥ 3.60B¥ 5.12B¥ 5.07B¥ 4.79B¥ 3.67B
EBITDA¥ 4.90B¥ 6.49B¥ 5.00B¥ 5.82B¥ 4.68B
Net Income¥ 2.84B¥ 4.06B¥ 3.97B¥ 3.72B¥ 2.92B
Balance Sheet
Cash & Short-Term Investments¥ 18.27B¥ 21.31B¥ 22.56B¥ 22.38B¥ 19.47B
Total Assets¥ 81.68B¥ 78.59B¥ 74.67B¥ 66.12B¥ 59.76B
Total Debt¥ 12.37B¥ 11.70B¥ 11.43B¥ 9.92B¥ 9.56B
Net Debt-¥ -9.61B¥ -11.07B¥ -12.45B¥ -9.91B
Total Liabilities¥ 43.91B¥ 41.91B¥ 41.03B¥ 34.79B¥ 31.55B
Stockholders' Equity¥ 35.90B¥ 34.92B¥ 32.07B¥ 29.06B¥ 26.14B
Cash Flow
Free Cash Flow¥ 2.31B¥ 2.48B¥ 5.62B¥ 4.42B-
Operating Cash Flow¥ 3.44B¥ 4.10B¥ 7.00B¥ 5.67B¥ 585.19M
Investing Cash Flow-¥ -3.11B---
Financing Cash Flow-¥ -1.98B¥ 45.95M-¥ 1.44B
Currency in CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Company Earnings and Revenue History

Guangzhou Baiyunshan Pharmaceutical Holdings Company Debt to Assets

Guangzhou Baiyunshan Pharmaceutical Holdings Company Cash Flow

Guangzhou Baiyunshan Pharmaceutical Holdings Company Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis